Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · National Health Investors (NHI)

NHI Q2 EPS rises 45.6% to $1.15; normalized FFO per share dips 2.5% to $1.19

Mixed Impact 3 of 5 earnings Written later

National Health Investors reported second quarter 2026 results, with diluted earnings per share of $1.15 versus $0.79 a year earlier, helped by $22.0 million of property disposition gains. Normalized FFO per diluted share fell 2.5% to $1.19 for the quarter, though the company also raised its quarterly dividend to $0.94 from $0.92 and issued 2026 full-year NAREIT FFO guidance of $4.74 to $4.79 per diluted share.

Key points

  • Diluted EPS of $1.15 for Q2 2026 vs. $0.79 in Q2 2025; six-month diluted EPS of $1.97 vs. $1.53
  • Normalized FFO per diluted share of $1.19 for Q2 2026 vs. $1.22 in Q2 2025; six-month figure rose 2.1% to $2.42
  • Quarterly dividend increased to $0.94 per share from $0.92, payable November 6, 2026
  • NHC portfolio sale closed July 1, 2026 for $560.0 million in cash consideration

The filing

CompanyNational Health Investors (NHI)
Form8-K, current report
Filed with the SECAug 10, 2026, 4:10 PM ET
Accession number0000877860-26-000200

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:39 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.